Login / Signup

Baduanjin for ischemic heart failure with mildly reduced/preserved ejection fraction (BEAR Trial): A randomized controlled trial.

Jingen LiMeili YuYanhui WangSiming LiSiwei LiXue FengRuijie LiKeji ChenHao Xu
Published in: Journal of evidence-based medicine (2024)
Adding Baduanjin to exercise-based cardiac rehabilitation for patients with ischemic HFmrEF or HFpEF are generally safe and could provide significant improvements in exercise capacity and quality of life.
Keyphrases